Phenox Gmbh
Clinical trials sponsored by Phenox Gmbh, explained in plain language.
-
Can a tiny mesh device defuse brain aneurysms? a registry investigates
Disease control Recruiting nowThis study is a registry that will follow about 200 people with brain aneurysms who are treated with a flow diverter device (p64, p64 MW, or p48 MW). The goal is to see how safe and effective these devices are in real-world practice across France. Participants will be monitored f…
Sponsor: Phenox GmbH • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Massive registry launches to see how brain aneurysm devices perform in real life
Knowledge-focused Recruiting nowThis registry is following 5,000 people who receive WallabyPhenox flow diverters or other devices to treat brain aneurysms, dissections, or perforations. Researchers are tracking safety, performance, and patient outcomes over time in routine hospital practice. The goal is to gath…
Sponsor: Phenox GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC